Atlas Trials

Short-term Safety, Efficacy and Mode of Action of Apremilast in Moderate Suppurative Hidradenitis

Clinical trial NCT03049267 · COMPLETED

Trial details

NCT number
NCT03049267
Sponsor
M.B.A. van Doorn
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hidradenitis Suppurativa
Start date
2017-02-02
Primary completion
2017-12-06
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.